tence. Despite the VTR1, trainers (understandably) never addressed the problems of failing a non-competent registrar, just as most people would be uncomfortable with the British School of Motoring both teaching and assessing future drivers on the road. The West of Scotland experience has been mirrored nationally with a failure rate of 5%. This year, two of our trainers have left the final decision to summative assessment as they felt unwilling to fail the registrar themselves.
Criterion referencing using a defined passmark is now a recognized benchmark for assessment methodology. What made the assessors 'expert' was their extra training that led to better reliability in marking. As we mentioned in our paper, two attempts to run training courses for audit, much of which would have been based on using the assessment criteria to produce a more rigorous approach to audit, had to be cancelled owing to lack of interest.
We have never stated that our criteria are absolute, but the overriding advantage of defined criteria is the transparency with which trainers and registrars alike understand the key issues in which they are being assessed, and the fairness of such a system, which (in theory), allows a 100% pass rate. The five projects were chosen to maximize assessor agreement and not to highlight the maximum inadequacy of the projects. The method for developing the marking instrument in consultation with all trainers in the region is described elsewhere. 2 It is against this backdrop that, in the West of Scotland at least, we now clearly understand some of the difficulties in implementing audit within training practices and are attempting to raise the profile of assessing quality of care in a rigorous and mature way for a future generation of general practitioners. Willis (July Journal) report that a small proportion of men in the British Regional Heart Study cohort are receiving aspirin after myocardial infarction (44% taking daily aspirin, 58% taking less than daily aspirin) or after coronary artery bypass graft (52% taking daily aspirin, 69% taking less than daily aspirin). We believe that these results are an under-estimate of current clinical practice. Since their survey was undertaken (November 1992), the major systematic review concerning the effectiveness of antiplatelet therapy has been published," 2 and an evidence-based summary of this review has been distributed to all GPs in the United Kingdom. 34 A prospective audit carried out by Avon Primary Care Audit Group (PCAG) in 21 general practices covering 148 000 patients revealed that more people with these conditions are now receiving aspirin and that this proportion is increasing over time ( Table 1) .
Some of the observed differences between our study and that of McCallum may be due to the fact that we asked practices about prescribed medication or known over-the-counter medication, while they surveyed patients directly.
Nevertheless, it does appear that the prescription and uptake of aspirin has increased since 1992. Perhaps explanations for the positive test other than the onset of diabetes had become more convincing to the subjects before they were followed up, leading them to doubt the validity of their selfadministered screening tests. For example, students offered tests for a fictitious risk factor subsequently rated the test as being less accurate if they were diagnosed as being at risk rather than testing negative. The tendency to denigrate the test accuracy was even more marked when told that they alone had tested positive out of the group.4 The explanation offered for these findings was that more thought is given to undesirable than desirable facts. In other words, if it is good news, then relatively little further attention is offered. If it is bad news, then a complex set of thoughts is triggered in which alternative (and perhaps more acceptable) explanations might be uncovered.
JAMES
Reluctance to acknowledge a diagnosis of diabetes is only one of a number of social and psychological issues that need to be addressed through further research alongside current work to establish whether screening for type 2 diabetes is likely to be effective.
Sir, In their study on postal screening for diabetes (June Journal), Dr Bullimore et al express surprise at finding that some patients 'showed surprisingly negative attitudes to the diagnosis of an illness, and
